5:28 PM
Mar 19, 2013
 |  BC Extra  |  Politics & Policy

Wyden seeking list of drugs based on NIH research

Sen. Ron Wyden (D-Ore.) sent a JAK-3 that he said helped lead to the development of rheumatoid arthritis drug Xeljanz tofacitinib from Pfizer Inc. (NYSE:PFE). According to Wyden, "taxpayer-funded...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >